7CFO
Crystal structure of human RXRalpha ligand binding domain complexed with CBTF-EE.
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | PHOTON FACTORY BEAMLINE AR-NW12A |
Synchrotron site | Photon Factory |
Beamline | AR-NW12A |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2018-12-13 |
Detector | DECTRIS PILATUS3 2M |
Wavelength(s) | 1.0 |
Spacegroup name | P 1 21 1 |
Unit cell lengths | 50.757, 99.432, 93.598 |
Unit cell angles | 90.00, 98.31, 90.00 |
Refinement procedure
Resolution | 47.140 - 2.150 |
R-factor | 0.22283 |
Rwork | 0.221 |
R-free | 0.26633 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 5zqu |
RMSD bond length | 0.009 |
RMSD bond angle | 2.001 |
Data reduction software | HKL-2000 |
Data scaling software | SCALEPACK |
Phasing software | MOLREP |
Refinement software | REFMAC (5.8.0238) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 47.140 | 2.230 |
High resolution limit [Å] | 2.150 | 2.150 |
Rmerge | 0.081 | 0.498 |
Number of reflections | 48015 | 1815 |
<I/σ(I)> | 16.2 | 1.7 |
Completeness [%] | 95.6 | |
Redundancy | 6.5 | |
CC(1/2) | 0.996 | 0.860 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 7 | 295 | 5% [v/v] tacsimateTM [pH 7.0], 0.1 M HEPES [pH 7.0], and 10% [w/v] PEGMME5000 |